Phosphate for acute pancreatitis
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests if giving phosphate through a vein can help people with acute pancreatitis. It's for adults who come to the emergency room with pancreatitis and can start treatment within 24 hours of being admitted to the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have acute pancreatitis (severe upper belly pain, high enzyme levels in blood, or signs on scans)
- Treatment must be started within 24 hours of being admitted to the hospital
- You or your legal representative must agree to be in the trial
- You must not have high potassium, high or very low calcium, or advanced kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving extra IV fluids before, during, and after an ERCP procedure can help prevent a common complication called post-ERCP pancreatitis (inflammation of the pancreas). If you are scheduled for an ERCP, you may be eligible to participate.
This trial compares three common pain relievers (paracetamol, ibuprofen, and metamizole) to see which works best for children with acute pancreatitis. It aims to help your child feel better faster with fewer side effects.
This trial tests whether adding phosphate granules to feeding tubes can help raise low phosphate levels in ICU patients who are already receiving nutrition through a feeding tube.
This study tests if giving the blood thinner heparin early in acute pancreatitis can prevent organs from failing. It looks at whether heparin helps reduce serious complications and improve recovery.
This trial tests a standard way for doctors to manage phosphate levels (a mineral in your blood) in intensive care patients. The goal is to see if a set protocol helps keep your phosphate levels healthy, which could support your overall recovery.
This trial tests an investigational medicine called SGC001 given as an injection to people with severe acute pancreatitis, a serious inflammation of the pancreas. The study aims to see if the drug is safe and helpful, and to gather early information on how it works.
Hear when a new Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.